Thomas F. Barth
Albert Einstein Allee 11
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms.
Journal: The Journal of pathology
Published: May 16, 2024
Host factor PLAC8 is required for pancreas infection by SARS-CoV-2.
Journal: Communications medicine
Published: October 23, 2023
DNA methylation-associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis.
Journal: The Journal of pathology
Published: October 17, 2022
Targetable alterations in primary extranodal diffuse large B-cell lymphoma.
Journal: EJHaem
Published: March 14, 2022
Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 12, 2022
Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
Journal: The Journal of pathology
Published: November 21, 2021
Comparison of superb microvascular imaging (SMI) quantified with ImageJ to quantified contrast-enhanced ultrasound (qCEUS) in liver metastases-a pilot study.
Journal: Quantitative imaging in medicine and surgery
Published: April 07, 2021
Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas.
Journal: Pathology oncology research : POR
Published: March 10, 2021
Establishing and evaluation of a polymerase chain reaction for the detection of Echinococcus multilocularis in human tissue.
Journal: PLoS neglected tropical diseases
Published: July 06, 2020
Combining Computed Tomography and Histology Leads to an Evolutionary Concept of Hepatic Alveolar Echinococcosis.
Journal: Pathogens (Basel, Switzerland)
Published: July 01, 2020
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma.
Journal: Future oncology (London, England)
Published: April 01, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Journal: United European gastroenterology journal
Published: March 28, 2020
Last Updated: 09/26/2026